The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Endothelin-A Receptor Antagonist–Mediated Vasodilatation Is Attenuated by Inhibition of Nitric Oxide Synthesis and by Endothelin-B Receptor Blockade
Open accessAbstract
Background —The role of endothelin (ET)-1 in maintenance of basal vascular tone has been demonstrated by local and systemic vasodilatation to endothelin receptor antagonists in humans. Although the constrictor effects mediated by the vascular smooth muscle ET A receptors are clear, the contribution from endothelial and vascular smooth muscle ET B receptors remains to be defined. The present study, in human forearm resistance vessels in vivo, was designed to further investigate the physiological function of ET A and ET B receptor subtypes in human blood vessels and determine the mechanism underlying the vasodilatation to the ET A -selective receptor antagonist BQ-123. Methods and Results —Two studies were performed, each in groups of eight healthy subjects. Brachial artery infusion of BQ-123 caused significant forearm vasodilatation in both studies. This vasodilatation was reduced by 95% ( P =.006) with inhibition of the endogenous generation of nitric oxide and by 38% ( P <.001) with coinfusion of the ET B receptor antagonist BQ-788. In contrast, inhibition of prostanoid generation did not affect the response to BQ-123. Infusion of BQ-788 alone produced a 20% reduction in forearm blood flow ( P <.001). Conclusions —Selective ET A receptor antagonism causes vasodilatation of human forearm resistance vessels in vivo. This response appears to result in major part from an increase in nitric oxide generation. ET B receptor antagonism either alone or on a background of ET A antagonism causes local vasoconstriction, indicating that ET B receptors in blood vessels respond to ET-1 predominantly by causing vasodilatation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
Cloning and expression of a cDNA encoding an endothelin receptor
Arai, H., Hori, S., Aramori, I., Ohkubo, H., & Nakanishi, S. (1990) · Nature · doi:10.1038/348730a0 · Cited by 2,578
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
Sakurai, T., Yanagisawa, M., Takuwat, Y., Miyazakit, H., Kimura, S., Goto, K., & Masaki, T. (1990) · Nature · doi:10.1038/348732a0 · Cited by 2,424
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
Vallance, P., Collier, J., & Moncada, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91013-1 · Cited by 1,590
de Nucci, G., Thomas, R., D'Orleans-Juste, P., Antunes, E., Walder, C., Warner, T. D., & Vane, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9797 · Cited by 1,400
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.
Boulanger, C., & Lüscher, T. F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114477 · Cited by 1,045
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor
Ihara, M., Noguchi, K., Saeki, T., Fukuroda, T., Tsuchida, S., Kimura, S., Fukami, T., Ishikawa, K., Nishikibe, M., & Yano, M. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90331-i · Cited by 869
Contribution of endogenous generation of endothelin-1 to basal vascular tone
HAYNES, W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92827-4 · Cited by 591
Ishikawa, K., Ihara, M., Noguchi, K., Mase, T., Mino, N., Saeki, T., Fukuroda, T., Fukami, T., Ozaki, S., & Nagase, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4892 · Cited by 570
Calver, A., Collier, J., & Vallance, P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116149 · Cited by 522
Cited by
Mechanisms of drug combinations: interaction and network perspectives
Jia, J., Zhu, F., Ma, X., Cao, Z. W., Li, Y. X., & Chen, Y. Z. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2683 · Cited by 969
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
The Endothelium and Its Role in Regulating Vascular Tone
Sandoo, A., Veldhuijzen van Zanten, J. J. C. S., Metsios, G. S., Carroll, D., & Kitas, G. D. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010302 · Cited by 814
Vascular Adaptation to Exercise in Humans: Role of Hemodynamic Stimuli
Green, D. J., Hopman, M. T. E., Padilla, J., Laughlin, M. H., & Thijssen, D. H. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00014.2016 · Cited by 821
Davenport, A. P., Hyndman, K. A., Dhaun, N., Southan, C., Kohan, D. E., Pollock, J. S., Pollock, D. M., Webb, D. J., & Maguire, J. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011833 · Cited by 772
Self-citationDeanfield, J., Donald, A., Ferri, C., Giannattasio, C., Halcox, J., Halligan, S., Lerman, A., Mancia, G., Oliver, J. J., Pessina, A. C., et al. (2005) · Journal of Hypertension · doi:10.1097/00004872-200501000-00004 · Cited by 634
Self-citationLüscher, T. F., & Barton, M. (2000) · Circulation · doi:10.1161/01.cir.102.19.2434 · Cited by 596
The importance of endothelin-1 for vascular dysfunction in cardiovascular disease
BOHM, F., & PERNOW, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.06.004 · Cited by 516
Moraes, D. L., Colucci, W. S., & Givertz, M. M. (2000) · Circulation · doi:10.1161/01.cir.102.14.1718 · Cited by 401
Endothelial function and coronary artery disease
Kinlay, S., Libby, P., & Ganz, P. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200108000-00003 · Cited by 384
Endothelin as a regulator of cardiovascular function in health and disease
Haynes, W. G., & Webb, D. J. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816080-00001 · Cited by 360
Self-citationVenous occlusion plethysmography in cardiovascular research: methodology and clinical applications
Wilkinson, I. B., & Webb, D. J. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01495.x · Cited by 355
Self-citationPharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist
Iglarz, M., Binkert, C., Morrison, K., Fischli, W., Gatfield, J., Treiber, A., Weller, T., Bolli, M. H., Boss, C., Buchmann, S., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142976 · Cited by 329
Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches
Park, K.-H., & Park, W. J. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.9.1213 · Cited by 327
Vascular endothelin in hypertension
Schiffrin, E. L. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.03.004 · Cited by 305
Barton, M., & Yanagisawa, M. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-059 · Cited by 305
Insulin Stimulates Both Endothelin and Nitric Oxide Activity in the Human Forearm
Cardillo, C., Nambi, S. S., Kilcoyne, C. M., Choucair, W. K., Katz, A., Quon, M. J., & Panza, J. A. (1999) · Circulation · doi:10.1161/01.cir.100.8.820 · Cited by 301
Endothelin: 30 Years From Discovery to Therapy
Barton, M., & Yanagisawa, M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12105 · Cited by 295
Role of Endothelin in the Increased Vascular Tone of Patients With Essential Hypertension
Cardillo, C., Kilcoyne, C. M., Waclawiw, M., Cannon, R. O., & Panza, J. A. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.753 · Cited by 285
Increased Activity of Endogenous Endothelin in Patients With Type II Diabetes Mellitus
Cardillo, C., Campia, U., Bryant, M. B., & Panza, J. A. (2002) · Circulation · doi:10.1161/01.cir.0000032260.01569.64 · Cited by 259
The Endothelin System and Its Antagonism in Chronic Kidney Disease
Dhaun, N., Goddard, J., & Webb, D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121256 · Cited by 256
Self-citationEndothelin-A -Mediated Vasoconstriction During Exercise With Advancing Age
Barrett-O’Keefe, Z., Ives, S. J., Trinity, J. D., Morgan, G., Rossman, M. J., Donato, A. J., Runnels, S., Morgan, D. E., Gmelch, B. S., Bledsoe, A. D., et al. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu065 · Cited by 43
Transcriptional control of human adipose tissue blood flow
Perez‐Matute, P., Neville, M. J., Tan, G. D., Frayn, K. N., & Karpe, F. (2009) · Obesity · doi:10.1038/oby.2008.606 · Cited by 32
Metadata
- Authors
- Verhaar, M. C., Strachan, F. E., Newby, D. E., Cruden, N. L., Koomans, H. A., Rabelink, T. J., & Webb, D. J.
- Venue
- Circulation
- Published
- 1998-03-03
- Volume
- 97
- Issue
- 8
- Pages
- 752-756
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1992583442
- Cited by
- 453
- References
- 31
- FWCI
- 21.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.